Lion E - Search Results

1

Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.

Anguille S, Lion E, Tel J, de Vries IJ, Couderé K, Fromm PD, Van Tendeloo VF, Smits EL, Berneman ZN. Anguille S, et al. Among authors: lion e. PLoS One. 2012;7(12):e51851. doi: 10.1371/journal.pone.0051851. Epub 2012 Dec 28. PLoS One. 2012. PMID: 23284789 Free PMC article.

2

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.

Lion E, Smits EL, Berneman ZN, Van Tendeloo VF. Lion E, et al. Leuk Res. 2009 Apr;33(4):539-46. doi: 10.1016/j.leukres.2008.08.020. Epub 2008 Oct 9. Leuk Res. 2009. PMID: 18845337

3

The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells.

Smits EL, Cools N, Lion E, Van Camp K, Ponsaerts P, Berneman ZN, Van Tendeloo VF. Smits EL, et al. Among authors: lion e. Cancer Immunol Immunother. 2010 Jan;59(1):35-46. doi: 10.1007/s00262-009-0721-8. Epub 2009 May 16. Cancer Immunol Immunother. 2010. PMID: 19449004 Free PMC article.

4

Quantification of IFN-gamma produced by human purified NK cells following tumor cell stimulation: comparison of three IFN-gamma assays.

Lion E, Smits EL, Berneman ZN, Van Tendeloo VF. Lion E, et al. J Immunol Methods. 2009 Oct 31;350(1-2):89-96. doi: 10.1016/j.jim.2009.08.014. Epub 2009 Sep 4. J Immunol Methods. 2009. PMID: 19733573

5

Interferon-α in acute myeloid leukemia: an old drug revisited.

Anguille S, Lion E, Willemen Y, Van Tendeloo VF, Berneman ZN, Smits EL. Anguille S, et al. Among authors: lion e. Leukemia. 2011 May;25(5):739-48. doi: 10.1038/leu.2010.324. Epub 2011 Jan 28. Leukemia. 2011. PMID: 21274002 Review.

6

Dendritic cell vaccine therapy for acute myeloid leukemia: questions and answers.

Anguille S, Lion E, Smits E, Berneman ZN, van Tendeloo VF. Anguille S, et al. Among authors: lion e. Hum Vaccin. 2011 May;7(5):579-84. doi: 10.4161/hv.7.5.14652. Epub 2011 May 1. Hum Vaccin. 2011. PMID: 21422813

7

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.

Lion E, Anguille S, Berneman ZN, Smits EL, Van Tendeloo VF. Lion E, et al. PLoS One. 2011;6(6):e20952. doi: 10.1371/journal.pone.0020952. Epub 2011 Jun 17. PLoS One. 2011. PMID: 21698118 Free PMC article.

8

Natural killer cell immune escape in acute myeloid leukemia.

Lion E, Willemen Y, Berneman ZN, Van Tendeloo VF, Smits EL. Lion E, et al. Leukemia. 2012 Sep;26(9):2019-26. doi: 10.1038/leu.2012.87. Epub 2012 Mar 26. Leukemia. 2012. PMID: 22446501 Review.

9

Human tears reveal insights into corneal neovascularization.

Zakaria N, Van Grasdorff S, Wouters K, Rozema J, Koppen C, Lion E, Cools N, Berneman Z, Tassignon MJ. Zakaria N, et al. Among authors: lion e. PLoS One. 2012;7(5):e36451. doi: 10.1371/journal.pone.0036451. Epub 2012 May 9. PLoS One. 2012. PMID: 22590547 Free PMC article. Clinical Trial.

10

Dendritic cell vaccination in acute myeloid leukemia.

Anguille S, Willemen Y, Lion E, Smits EL, Berneman ZN. Anguille S, et al. Among authors: lion e. Cytotherapy. 2012 Jul;14(6):647-56. doi: 10.3109/14653249.2012.693744. Cytotherapy. 2012. PMID: 22686130 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters